GPCR icon

Structure Therapeutics
GPCR

Overview Fund Activity

48 hedge funds and large institutions have $699M invested in Structure Therapeutics in 2023 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 11 increasing their positions, 10 reducing their positions, and 4 closing their positions.

Holders
48
Holders Change
+10
Holders Change %
+26.32%
% of All Funds
0.76%
Holding in Top 10
4
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+300%
% of All Funds
0.06%
New
14
Increased
11
Reduced
10
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$73.7M
2
MIM
2
Monashee Investment Management
Massachusetts
$22.8M
3
CC
3
Casdin Capital
New York
$41.4M
4
DM
4
Deerfield Management
New York
$26.1M
5
DCM
5
Driehaus Capital Management
Illinois
$47.2M

Top Sellers

1
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$3.22M
2
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$8M
3
Franklin Resources
3
Franklin Resources
California
$10.4M
4
AG
4
Artal Group
Luxembourg
$0
5
Federated Hermes
5
Federated Hermes
Pennsylvania
$42.2M
Name Market Value Shares Shares
Change 		Shares
Change %
CSS
51
Cubist Systematic Strategies
Connecticut
– – -805 Closed
Morgan Stanley
52
Morgan Stanley
New York
– – -11 Closed
CFGS
53
Concourse Financial Group Securities
Alabama
– – – –
DKCM
54
Davidson Kempner Capital Management
New York
– – – –
1 2
3